Neuroscientific Biopharmaceuticals Ltd. (AU:NSB) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neuroscientific Biopharmaceuticals Ltd. has announced the cessation of 1,175,000 options due to expiry without exercise or conversion on April 6, 2024. This financial update, relevant for investors tracking the company’s capital structure, reflects changes in the securities issued by the firm.
For further insights into AU:NSB stock, check out TipRanks’ Stock Analysis page.